IDEAYA Biosciences, Inc.
IDYA- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001676725
In the last 90 days, IDEAYA Biosciences, Inc. insiders filed 0 open-market purchases and 1 sale; 285 institutions reported holding it in 13F filings for Q2 2026, worth $3.80B in total; no superinvestor holds it.
Q3 2022 vs. Q2 2022
How the institutions holding IDEAYA Biosciences, Inc. changed between Q2 2022 and Q3 2022.
All holders in Q3 2022All holders in Q2 2022
| Measure | Q2 2022 | Q3 2022 | Change |
|---|---|---|---|
| Holders | 96 | 112 | +16 |
| Shares | 35.4M | 44.7M | +9.28M (+26.2%) |
| Value | $489.0M | $667.1M | +$178.2M (+36.4%) |
New holders (28)
Institutions that held IDEAYA Biosciences, Inc. at the end of Q3 2022 but not at the end of Q2 2022.
Sold out (12)
Institutions that held IDEAYA Biosciences, Inc. at the end of Q2 2022 and filed for Q3 2022 without it.
| Institution | Shares, Q2 2022 | Value, Q2 2022 |
|---|---|---|
| Point72 Asset Management, L.P. | 1,509,000 | $20.8M |
| Alphabet Inc. | 753,187 | $10.4M |
| ACT Capital Management, LLC | 173,500 | $2.39M |
| HighVista Strategies LLC | 130,380 | $1.80M |
| Millennium Management LLC | 99,982 | $1.38M |
| Panagora Asset Management Inc | 24,372 | $336.0K |
| Victory Capital Management Inc | 23,083 | $319.0K |
| Cornercap Investment Counsel Inc | 15,896 | $219.0K |
| ExodusPoint Capital Management, LP | 13,099 | $181.0K |
| Lazard Asset Management LLC | 12,027 | $165.0K |
| Captrust Financial Advisors | 738 | $10.0K |
| Quadrant Capital Group LLC | 186 | $3.00K |